Instil Bio (TIL) Competitors

Instil Bio (NASDAQ:TIL) and Phathom Pharmaceuticals (NASDAQ:PHAT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Does the media prefer TIL or PHAT?

In the previous week, Phathom Pharmaceuticals had 5 more articles in the media than Instil Bio. MarketBeat recorded 10 mentions for Phathom Pharmaceuticals and 5 mentions for Instil Bio. Phathom Pharmaceuticals' average media sentiment score of 0.16 beat Instil Bio's score of -0.06 indicating that Phathom Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Instil Bio	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phathom Pharmaceuticals	1 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend TIL or PHAT?

Instil Bio presently has a consensus target price of $119.00, suggesting a potential upside of 321.24%. Phathom Pharmaceuticals has a consensus target price of $17.50, suggesting a potential upside of 67.14%. Given Instil Bio's higher possible upside, equities analysts clearly believe Instil Bio is more favorable than Phathom Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Instil Bio	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
Phathom Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more volatility and risk, TIL or PHAT?

Instil Bio has a beta of 2.16, indicating that its share price is 116% more volatile than the S&P 500. Comparatively, Phathom Pharmaceuticals has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500.

Is TIL or PHAT more profitable?

Instil Bio has a net margin of 0.00% compared to Phathom Pharmaceuticals' net margin of -289.51%. Phathom Pharmaceuticals' return on equity of 0.00% beat Instil Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Instil Bio	N/A	-51.67%	-32.77%
Phathom Pharmaceuticals	-289.51%	N/A	-90.40%

Do institutionals and insiders hold more shares of TIL or PHAT?

60.6% of Instil Bio shares are owned by institutional investors. Comparatively, 99.0% of Phathom Pharmaceuticals shares are owned by institutional investors. 47.2% of Instil Bio shares are owned by insiders. Comparatively, 23.0% of Phathom Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has higher valuation and earnings, TIL or PHAT?

Instil Bio has higher earnings, but lower revenue than Phathom Pharmaceuticals. Instil Bio is trading at a lower price-to-earnings ratio than Phathom Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Instil Bio	N/A	N/A	-$74.14M	-$11.97	-2.36
Phathom Pharmaceuticals	$55.25M	13.44	-$334.33M	-$4.73	-2.21

Summary

Instil Bio and Phathom Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks.